BioPharm Insight Overview
BioPharm Insight™ is an on-line database containing the most up-to-date information, research and journalism available across the entire lifesciences marketplace. Our service provides an extraordinary depth of coverage and is updated daily to ensure that you have access to the most current and relevant insight and data. BioPharm Insight contains powerful information sets including:
Pharmawire Intelligence – our global network of journalists (located primarily in New York, London and Hong Kong) are covering the most important situations taking place in the Life Sciences industry. Pharmawire journalists tap into insight from leading CEOs, scientists, clinicians, lawyers and other experts to provide forward looking insight into drug pipelines, upcoming litigation (including patent expirations), drug licensing deals and mergers & acquisitions.
View the Pharmawire 'Article of the Week'
Investigational Drugs – analytics on over 25,000 investigational and 23,000 approved drugs, drug licensing deals, and detailed company profiles.
Drug Forecasts − sales and forecasts on over $475 billion in drug sales including powerful therapeutic summaries and forecasts.
Drug Licensing Deals – comprehensive information on drug licensing deals including payment terms, milestones, benchmarks, key executives and more.
Medical Devices – detailed profiles on over 100,000 medical devices and 20,000 medical device companies including investigational devices and powerful searching capabilities.
Company, Management, and Executive Profiles: Detailed profiles on over 3,000 Biotech and Pharmaceutical companies including information on their drug pipelines, licensing deals and analysis on the executives and managers that are driving change within the Biotech and Pharmaceutical universe. Find critical managers including drug program managers, business development executives, clinicians, regulatory and compliance.